Oruka Therapeutics, Inc. (ORKA) NASDAQ
64.59
+0.52(+0.81%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
64.59
+0.52(+0.81%)
Currency In USD
| Market Cap | 1.38B |
| Enterprise Value | 1.34B |
| P/E Ratio | -33.34 |
| PEG Ratio | -0.43 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 7.45 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -21.54 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.22 |
| Return On Equity | -0.25 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -83,000 |
| EBITDA | -121.97M |
| Net Income | -105.43M |
| Diluted EPS | -2.31 |
| Total Cash | 337.04M |
| Total Cash/Share | 6.19 |
| Total Debt | 1.93M |
| Total Debt/Equity | 0 |
| Current Ratio | 22.37 |
| Book Value Per Share | 8.67 |
| 52-Week Change | 562.46 |
| 52-Week High | 91 |
| 52-Week Low | 8.91 |
| Moving Average 50 Days | 53.01 |
| Moving Average 200 Days | 31.97 |
| Average Volume | 1.27M |
| Shares Outstanding | 37.45M |
| % Held by Institutions | 119.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | September 03, 2024 |